Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00290771
Status:
TERMINATED
Last Update Posted:
2011-05-16
First Post:
2006-02-10
Brief Title:
Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea HU in Patients With Recurrent Glioblastoma Multiforme GBM
Sponsor:
Novartis
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CSTI571H2201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
External Affairs
Old Organization:
Novartis